ECPG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ECPG looks like a good buy right now for a beginner with a long-term focus and $50,000-$100,000 to invest. The company just delivered a strong Q1 beat with sharp revenue, EPS, and net income growth, raised full-year collections guidance, and continues to improve leverage and capital deployment. Analyst sentiment is strongly positive with multiple recent target increases, and the stock still has room to run relative to the latest raised targets. While insider selling and bearish options positioning are negatives, the overall fundamental and analyst backdrop is strong enough to support a direct buy decision for a long-term investor who does not want to wait for a perfect entry.
Technically, ECPG is in a constructive longer-term trend because the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, short-term momentum is weaker: MACD histogram is -0.466 and negatively expanding, showing near-term pressure, while RSI_6 at 43.824 is neutral and not oversold. Price at 83.88 is below the pivot of 85.319 but still above support at 80.452, so the chart suggests a healthy trend with some short-term consolidation rather than a breakdown. For a long-term buyer, the technical setup is acceptable, though not strongly momentum-driven today.
["Q1 GAAP EPS of $3.86 beat expectations by $0.85", "Q1 revenue grew 21% year over year", "Company raised 2026 global collections guidance to about $2.8 billion, implying 8% YoY growth", "Encore repurchased $20 million of common stock in Q1", "Analysts continue to raise price targets and maintain bullish ratings", "Business metrics are improving with record collections, better margins, and lower leverage"]
["Insiders have been selling, with selling amount increasing 589.14% over the last month", "Options flow is bearish with put-call ratios above 2.7", "MACD is negative and worsening, signaling short-term weakness", "Hedge funds are neutral with no strong accumulation trend", "Similar candlestick pattern analysis suggests a weak next-week return outlook"]
In the latest reported quarter, Q1 2026, Encore Capital showed very strong growth. Revenue increased to 379.9 million, up 19.49% year over year, net income rose 84.30% to 86.2 million, and EPS doubled to 3.86, up 100% year over year. The company also beat expectations and raised collections guidance, which supports the view that operating momentum is improving meaningfully.
Analyst sentiment is clearly bullish and improving. Recent target hikes include Citizens raising its target to $108 from $90 and Truist raising to $100 from $80, both keeping Buy/Outperform ratings. Northland also raised its target to $78 from $70, and earlier Truist and Citizens both lifted targets after a strong Q4. The Wall Street pros view is positive overall: they cite stronger collections, better recoveries, higher EPS forecasts, and improved operating efficiency. The main pro case is sustained earnings and collections momentum; the con case is that recent insider selling and bearish options activity suggest some near-term caution, even though analysts remain constructive.
